BCG vaccination against tuberculosis: past disappointments and future hopes.

Trends in microbiology ·Vol. 3 ·No. 10 ·1995-10-00 ·Pages 397-401

Roche PW, Triccas JA, Winter N

Abstract

Three billion doses of the bacille Calmette-Guérin (BCG) vaccine have been given over the past 60 years. BCG has a widely variable ability to protect humans against tuberculosis. This article examines some of the reasons for this variability, and discusses ways in which BCG vaccination might be improved.

MeSH Terms

Animals BCG Vaccine/administration & dosage Forecasting Humans Tuberculosis/prevention & control

Chemicals

BCG Vaccine

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Roche P W

Centenary Institute of Cancer Medicine and Cell Biology, Newtown, NSW, Australia.

Triccas J A

Winter N

Article Info

Journal

Trends in microbiology

Abbr.

Trends Microbiol

ISSN

0966-842X

DOI

10.1016/s0966-842x(00)88986-6

Published

1995-10-00

Pages

397-401

Language

English

Region

England

NLM ID

9310916

Subset

External Links

PubMed source DOI: 10.1016/s0966-842x(00)88986-6 View journal details

Analysis Services

BCG vaccination against tuberculosis: past disappointments and future hopes.

Contact

WeChat Official Account